Investor Presentaiton

FY21 performance exceeded plan amid challenging conditions around Revenue up by 36%, EBITDA up by 41%.. PAT Up by 62% YoY CONSOLIDATED Fig in Crores FY20 FY21 % YOY Revenue 3,366 4,577 36% Gross Margin 45% 44% (~100)bps Overheads 801 994 24% EBITDA 719 1017 41% EBITDA as % Revenue 21% 22% 90 bps Net Profit 457 738 62% 41% 62% 35% 39% 3322 2466 EXPORTS FY20 719 1255 900 DOMESTIC FY21 1017 457 PAT EBITDA FY20 FY21 738 Pi Inspired by Science ✓ Proactive measures taken in supply chain and operations planning lead to limited Covid-19 disruption ✓ ~36% YoY revenue growth mainly driven by ✓ ~35% YoY growth in Exports contributed by volume growth of existing products and commercialization of 5 new products ✓ ~39% YoY growth in Domestic in line with the business plan ✓ Gross profit improved by 32% YoY and Gross Margin % broadly maintained at last year level despite change in product mix and reduced MEIS benefit in the 2nd half of FY ✓ EBITDA % improved with strong control on fixed overheads and operating leverage Lower ETR @ 21% due to new SEZ unit getting operational ✓ Significant improvement in Free Cash Flow @ Rs 303 Cr and Gross cash flow at Rs. ~900 Cr with contained capex and improved W/C management Q4 & FY21 Earnings Presentation 4

View entire presentation